Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Jul 19, 2017

Mylan to Report Second Quarter 2017 Financial Results on Aug. 9, 2017

Jul 13, 2017

FDA Oncologic Drugs Advisory Committee Unanimously Recommends Approval of Mylan and Biocon's Proposed Biosimilar Trastuzumab

Jun 10, 2017

Mylan and Biocon Present Clinical Data on Insulin Glargine at the American Diabetes Association's 77th Scientific Sessions

Jun 07, 2017

Mylan to Present at Goldman Sachs 38th Annual Global Healthcare Conference

Jun 02, 2017

Mylan Launches Generic Azilect® Tablets

Jun 02, 2017

Mylan Launches Generic Reclast® Injection

May 23, 2017

Theravance Biopharma and Mylan Report Additional Phase 3 Data for Revefenacin (TD-4208) in Several Presentations at 2017 ATS

May 17, 2017

Theravance Biopharma and Mylan to Present Additional Data for Revefenacin (TD-4208) in Several Presentations at 2017 ATS

May 16, 2017

Mylan to Present at UBS Global Healthcare Conference

May 16, 2017

Mylan Honors National Women's Health Week to Empower Women to Take Control of Their Health

Pagination

First page
Previous page
…
Page 17
Page 18
Page 19
Page 20
Current page 21
Page 22
Page 23
Page 24
Page 25
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.